Clobazam NDC 72162-2608

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-2608Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-2608Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-2608-2	72162260802	1 BOTTLE in 1 CARTON (72162-2608-2) / 120 mL in 1 BOTTLEMarketed from Apr 21, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clobazam
Generic name (nonproprietary): clobazam
Active ingredients: Clobazam — 2.5 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214404
Marketing start: Mar 24, 2022
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)
Identifiers: Product ID 72162-2608_ae2dff0e-07da-443d-bf10-c72a30c6f23dSPL ID ae2dff0e-07da-443d-bf10-c72a30c6f23dSPL set ID 75fcff4a-1b35-4d92-8477-ff5ce7427f5fRxCUI 1366192UNII 2MRO291B4U
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162260802 followed by a unit qualifier and the quantity

Package 72162-2608-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 21, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Clobazam oral suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older. Clobazam oral suspension is a benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214404

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214404
Product	Strength	Form · route	Labeler	Product NDC
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Aurobindo Pharma Limited	59651-401